glucosylsucrose
Description
glucosylsucrose: principle constituent of coupling sugar which is prepared from starch & sucrose; similar taste to cane sugar [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
erlose : A trisaccharide consisting of sucrose having an alpha-D-glucopyranosyl residue attached at the 4-position of the glucose ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 193471 |
| CHEBI ID | 55512 |
| SCHEMBL ID | 935091 |
| MeSH ID | M0086829 |
Synonyms (25)
| Synonym |
|---|
| beta-d-fructofuranosyl alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranoside |
| CHEBI:55512 |
| sucrosylglucose |
| glucosylsucrose |
| erlose |
| 13101-54-7 |
| (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
| alpha-d-glucopyranoside, beta-d-fructofuranosyl o-alpha-d-glucopyranosyl-(1-4)- |
| unii-c3uyo172pu |
| c3uyo172pu , |
| SCHEMBL935091 |
| W-201046 |
| alpha-maltosyl beta-fructofuranoside |
| fructomaltose |
| DTXSID10927037 |
| Q3056700 |
| fructofuranoside, o-.alpha.-d-glucopyranosyl-(1->4)-.alpha.-d-glucopyranosyl, .beta.-d- |
| (2r,3r,4s,5s,6r)-2-((2r,3s,4r,5r,6r)-6-((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2h-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol |
| F82969 |
| alpha-d-glc-(1->4)-alpha-d-glc-(1->2)-beta-d-fru |
| a-d-glucopyranoside,b-d-fructofuranosyl o-a-d-glucopyranosyl-(1(r)4)- |
| CS-0198511 |
| HY-139338 |
| AKOS040756633 |
| fructofuranoside, o-?-d-glucopyranosyl-(1?4)-?-d-glucopyranosyl, ?-d- (7ci); fructofuranoside, ?-maltosyl, ?-d- (6ci); glucopyranoside, ?-d-fructofuranosyl 4-o-?-d-glucopyranosyl-, ?-d- (8ci); ?-d-fructofuranosyl o-?-d-glucopyranosyl-(1?4)-?-d-glucopyrano |
Drug Classes (1)
| Class | Description |
|---|---|
| trisaccharide | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.33
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||